Neuropharmacological and molecular docking studies of xanthones from Swertia corymbosa

References

• Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602.
   PubMed Web of Science ®Google Scholar
• Akbar S, Subhan F, Karim N, et al. Characterization of 6-methoxyflavanone as a novel anxiolytic agent: a behavioral and pharmacokinetic approach. Eur J Pharmacol. 2017;801:19–27.
   PubMed Web of Science ®Google Scholar
• Treiman DM. GABAergic mechanisms in epilepsy. Epilepsia. 2001;42:8–12.
   PubMed Web of Science ®Google Scholar
• Davidson JR. First-line pharmacotherapy approaches for generalized anxiety disorder. J Clin Psychiatry. 2009;70:25–31.
   PubMed Web of Science ®Google Scholar
• Chebib M, Johnston GA. GABA-activated ligand gated ion channels: medicinal chemistry and molecular biology. J Med Chem. 2000;43:1427–1447.
   PubMed Web of Science ®Google Scholar
• Zeilhofer HU, Mohler H, Di Lio A. GABAergic analgesia: new insights from mutant mice and subtype-selective agonists. Trends Pharmacol Sci. 2009;30:397–402.
   PubMed Web of Science ®Google Scholar
• Mohler H, Fritschy JM, Crestani F, et al. Specific GABA(A) circuits in brain development and therapy. Biochem Pharmacol. 2004;68:1685–1690.
   PubMed Web of Science ®Google Scholar
• Mahendran G, Thamotharan G, Sengottuvelu S, et al. Evaluation of anticonvulsant, sedative, anxiolytic, and phytochemical profile of the methanol extract from the aerial parts of Swertia corymbosa (Griseb.) wight ex CB Clarke. Biomed Res Int. 2014;2014:542385.
   PubMedGoogle Scholar
• Mahendran G, Narmatha Bai V. Micropropagation, antioxidant properties and phytochemical assessment of Swertia corymbosa (Griseb.) Wight ex C. B. Clarke: a medicinal plant. Acta Physiol Plant. 2014;36:589–603.
   Web of Science ®Google Scholar
• Mahendran G, Manoj M, Murugesh E, et al. In vivo anti-diabetic, antioxidant and molecular docking studies of 1, 2, 8-trihydroxy-6-methoxy xanthone and 1, 2-dihydroxy-6-methoxyxanthone-8-O-beta-D-xylopyranosyl isolated from Swertia corymbosa. Phytomedicine. 2014;21:1237–1248.
   PubMed Web of Science ®Google Scholar
• Mahendran G, Manoj M, Rajendra Prasad KJ, et al. Antioxidants, anti-proliferative, anti-inflammatory, anti-diabetic and anti-microbial effects of isolated compounds from Swertia corymbosa (Grieb.) Wight ex C.B. Clark – an in vitro approach. Food Sci Hum Wellness. 2015;4:169–179.
   Google Scholar
• Vijayan R, Subbarao N, Manoharan N. In silico analysis of conformational changes induced by normal and mutation of macrophage infectivity potentiator catalytic residues and its interactions with rapamycin. Interdiscip Sci Comput Life Sci. 2015;7:326–333.
   PubMed Web of Science ®Google Scholar
• Vijayan R, Padmanaban E, Ponnusamy K, et al. Pharmacophore based virtual screening for identification of marine bioactive compounds as inhibitors against macrophage infectivity potentiator (MIP) protein of Chlamydia trachomatis. RSC Adv. 2016;6:18946–18957.
   Web of Science ®Google Scholar
• Peng WH, Hsieh MT, Lee YS, et al. Anxiolytic effect of seed of Ziziphus jujuba in mouse models of anxiety. J Ethnopharmacol. 2000;72:435–441.
   PubMed Web of Science ®Google Scholar
• Brown RE, Corey SC, Moore AK. Differences in measures of exploration and fear in MHC-congenic C57BL/6J and B6-H-2K mice. Behav Genet. 1999;29:263–271.
   Web of Science ®Google Scholar
• Ahmadiani A, Mandgary A, Sayyah M. Anticonvulsant effect of flutamide on seizures induced by pentylenetetrazole: involvement of benzodiazepine receptors. Epilepsia 2003;44:629–635.
   PubMed Web of Science ®Google Scholar
• Yemitan OK, Adeyemi OO. Protection against generalised seizured by Dalbergia saxatilis (Hook, F.) in the pentylenetetrazole and electroconvulsive models. West African J Pharm Drug Res. 2005;21:43–47.
   Google Scholar
• Adeyemi OO, Yemitan OK, Adebiyi OO. Sedative and anticonvulsant activities of the aqueous root extract of Sanseviera liberica Gerome & Labroy (Agavaceae). J Ethnopharmacol. 2007;113:111–114.
   PubMed Web of Science ®Google Scholar
• Balamurugan G, Muralidharan P, Selvarajan S. Anti-epileptic activity of poly herbal extract from Indian medicinal plants. J Sci Res. 2008;1:153–159.
   Google Scholar
• Adnaik RS, Pai PT, Sapakal VD, et al. Anxiolytic activity of Vitex negundo Linn. in experimental models of anxiety in mice. Int J Green Pharm. 2009;3:243–247.
   Google Scholar
• Farkas S, Berzsenyi P, Karpati E, et al. Simple pharmacological test battery to assess efficacy and side effect profile of centrally acting muscle relaxant drugs. J Pharmacol Toxicol Methods. 2005;52:264–273.
   PubMedGoogle Scholar
• Estrada-Reyes R, Lopez-Rubalcava C, Rocha L, et al. Anxiolytic-like and sedative actions of Rollinia mucosa: possible involvement of the GABA/benzodiazepine receptor complex. Pharm Biol. 2010;48:70–75.
   PubMed Web of Science ®Google Scholar
• Sali A, Blundell T. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 1993;234:779–815.
   PubMed Web of Science ®Google Scholar
• Laskowski RA, Rullmannn JA, MacArthur MW, et al. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR. 1996;8:477–486.
   PubMed Web of Science ®Google Scholar
• Huang B, Schroeder M. LIGSITEcsc: predicting ligand binding sites using the Connolly surface and degree of conservation. BMC Struct Biol. 2006;6:19.
   PubMed Web of Science ®Google Scholar
• Jones G, Willett P, Glen RC, et al. Development and validation of a genetic algorithm for flexible docking. J Mol Biol. 1997;267:727–748.
   PubMed Web of Science ®Google Scholar
• Morris GM, Goodsell DS, Halliday RS, et al. Automated docking using a lamarckian genetic algorithm and empirical binding free energy function. J Comput Chem. 1998;19:1639–1662.
   Web of Science ®Google Scholar
• Calcaterra NE, Barrow JC. Classics in chemical neuroscience: diazepam (Valium). ACS Chem Neurosci. 2014;5:253–260.
   PubMed Web of Science ®Google Scholar
• Vijayan R, Subbarao N, Mallick BN. In silico modeling of α1A-adrenoceptor: interaction of its normal and mutated active sites with noradrenaline as well as its agonist and antagonist. Am J Biochem Biotechnol. 2007;3:216–224.
   Google Scholar
• Lister RG. Ethologically-based animal-models of anxiety disorders. Pharmacol Therapeut. 1990;46:321–340.
   PubMed Web of Science ®Google Scholar
• Viedo VM, Milded GG, Rincon J, et al. Effect of an extract of Annona muricata on central nervous system. Pharmacol Online. 2006;3:342–347.
   Google Scholar
• Bum EN, Taiwe GS, Nkainsa LA, et al. Validation of anticonvulsant and sedative activity of six medicinal plants. Epilepsy Behav. 2009;14:454–458.
   PubMed Web of Science ®Google Scholar
• Rodgers RJ, Dalvi CB, Holmes A. Animal models of anxiety: an ethological perspective. Braz J Med Biol Res. 1997;30:289–304.
   PubMed Web of Science ®Google Scholar
• Olivier B, Molewijk E, van Oorschot R, et al. Rat pup ultrasonic vocalization: effects of benzodiazepine receptor ligands. Eur J Pharm. 1998;358:117–128.
   PubMed Web of Science ®Google Scholar
• Graeff FG, Garcia-Leal C, Del-Ben CM, et al. Does the panic attack activate the hypothalamic-pituitary-adrenal axis? An Acad Bras Ciênc. 2005;77:477–491.
   PubMed Web of Science ®Google Scholar
• Augustsson H, van de Weerd HA, Kruitwagen CL, et al. Effect of enrichment on variation and results in the light/dark test. Lab Anim. 2003;37:328–340.
   PubMedGoogle Scholar
• Sałat K, Gdula-Argasińska J, Malikowska N, et al. Effect of pregabalin on contextual memory deficits and inflammatory state-related protein expression in streptozotocin-induced diabetic mice. Naunyn Schmiedebergs Arch Pharmacol. 2017;389:613–623.
   Web of Science ®Google Scholar
• Gawande DY, Druzhilovsky D, Gupta RC, et al. Anticonvulsant activity and acute neurotoxic profile of Achyranthes aspera Linn. J Ethnopharmacol. 2017;202:97–102.
   PubMed Web of Science ®Google Scholar
• Perona MTG, Waters S, Hall FS, et al. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. Behav Pharmacol. 2008;19:566–574.
   PubMed Web of Science ®Google Scholar
• Al-Tubuly RA, Aburawi SM, Alghzewi EA, et al. The effect of sympathetic antagonists on the antidepressant action of alprazolam. Libyan J Med. 2008;3:78–83.
   PubMed Web of Science ®Google Scholar